Vitasora Health Ltd

Healthcare AU VHL

0.011AUD
-0.001(8.33%)

Last update at 2026-06-26T06:10:00Z

Day Range

0.010.01

LowHigh

52 Week Range

0.0090.04

LowHigh

Fundamentals

Previous Close 0.01
Market Cap28.08M
Volume2774999
P/E Ratio-
Dividend Yield-%
EBITDA-11.53452M
Revenue TTM5.01M
Revenue Per Share TTM0.003
Gross Profit TTM 5.21M
Diluted EPS TTM-0.01

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Income before tax	-10.10381M	-7.12925M	-5.77529M	-6.62431M	-11.04035M
Minority interest	-	-	-	-	-
Net income	-10.10504M	-7.12925M	-5.77529M	-6.62431M	-11.04035M
Selling general administrative	13.48M	6.94M	5.04M	4.68M	8.02M
Selling and marketing expenses	-	-	-	-	-
Gross profit	3.68M	0.46M	0.00493M	-0.00560M	-0.99338M
Reconciled depreciation	0.06M	0.06M	0.08M	0.08M	0.08M
Ebit	-	-	-	-	-
Ebitda	-	-	-	-	-
Depreciation and amortization	-	-	-	-	-
Non operating income net other	-	-	-	-	-
Operating income	-10.10381M	-7.64583M	-6.35186M	-7.07286M	-12.16192M
Other operating expenses	-	-	-	-	-
Interest expense	-	0.07M	0.01M	-	-
Tax provision	0.00124M	0.00000M	0.00000M	0.00000M	0.00000M
Interest income	0.00000M	-	-	-	-
Net interest income	-	-0.06502M	-0.01500M	-	-
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-	-	-	-	-
Total revenue	3.71M	0.46M	0.07M	0.25M	0.27M
Total operating expenses	13.81M	-	-	-	-
Cost of revenue	0.03M	-	0.07M	0.26M	1.26M
Total other income expense net	0.61M	0.58M	0.59M	0.45M	1.12M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-10.10504M	-7.12925M	-5.77529M	-6.62431M	-11.04035M
Net income applicable to common shares	-10.10504M	-	-	-	-
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Total assets	18.40M	6.19M	3.18M	4.21M	9.11M
Intangible assets	6.06M	0.08M	-	-	-
Earning assets	-	-	-	-	-
Other current assets	0.23M	0.22M	1.42M	0.03M	0.11M
Total liab	3.74M	3.55M	2.35M	1.20M	1.54M
Total stockholder equity	14.67M	2.64M	0.83M	3.01M	7.57M
Deferred long term liab	-	-	-	-	-
Other current liab	0.13M	-	0.29M	0.33M	0.10M
Common stock	-	-	-	-	-
Capital stock	162.92M	140.55M	132.10M	128.84M	127.09M
Retained earnings	-150.77057M	-141.61095M	-138.05254M	-133.31255M	-126.34628M
Other liab	-	-	-	-	-
Good will	6.95M	1.96M	-	-	-
Other assets	-	-	-	-	-
Cash	0.39M	0.76M	0.15M	1.22M	7.97M
Cash and equivalents	-	-	-	-	-
Total current liabilities	3.66M	3.43M	2.24M	1.20M	1.47M
Current deferred revenue	-	-	-	-	-
Net debt	-	0.41M	-	-	-
Short term debt	-	-	-	-	-
Short long term debt	-	1.18M	-	-	-
Short long term debt total	-	-	-	-	-
Other stockholder equity	-	-	-	-	-
Property plant equipment	-	-	-	-	-
Total current assets	5.34M	4.03M	3.00M	4.12M	8.95M
Long term investments	-	-	-	-	-
Net tangible assets	-	-	-	-	-
Short term investments	0.03M	0.03M	-	-	-
Net receivables	1.51M	0.32M	0.00286M	-	0.10M
Long term debt	-	-	-	-	-
Inventory	2.88M	2.75M	1.23M	2.65M	0.54M
Accounts payable	2.80M	1.71M	1.51M	0.52M	1.08M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	-	-	-
Deferred long term asset charges	-	-	-	-	-
Non current assets total	13.07M	2.16M	0.18M	0.08M	0.16M
Capital lease obligations	0.06M	0.12M	0.15M	0.07M	0.14M
Long term debt total	-	-	-	-	-

Breakdown	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Investments	1.13M	-1.88708M	-0.02180M	-0.00227M	-0.05425M
Change to liabilities	-	-	-	-	-
Total cashflows from investing activities	1.13M	-	-	-	-
Net borrowings	-	-	-	-	-
Total cash from financing activities	7.66M	9.13M	3.46M	1.64M	11.79M
Change to operating activities	-	-	-	-	-
Net income	-10.10504M	-7.12925M	-5.77529M	-4.54779M	-11.04035M
Change in cash	-0.36863M	0.60M	-1.05272M	-6.84092M	4.39M
Begin period cash flow	0.76M	0.15M	1.22M	7.97M	3.55M
End period cash flow	0.39M	0.76M	0.15M	1.22M	7.97M
Total cash from operating activities	-9.16761M	-	-	-	-
Issuance of capital stock	7.92M	8.81M	3.65M	1.67M	13.08M
Depreciation	-	-	-	-	-
Other cashflows from investing activities	1.13M	-	-	-	-
Dividends paid	-	-	-	-	-
Change to inventory	-	-	-	-	-
Change to account receivables	-	-	-	-	-
Sale purchase of stock	7.92M	-0.55985M	-0.39133M	-0.03307M	-0.54735M
Other cashflows from financing activities	-0.25718M	-	-	-	-
Change to netincome	-	-	-	-	-
Capital expenditures	0.00000M	0.00000M	0.02M	0.00227M	0.05M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	0.62M	-	-	-	-
Stock based compensation	-	-	-	-	-
Other non cash items	-	-	-	-	-
Free cash flow	-9.16761M	-6.64135M	-4.51199M	-8.47985M	-7.39335M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company	Change (AUD)	Price (AUD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
VHL Vitasora Health Ltd	-0.001 8.33%	0.01	-	0.93	5.60	1.79	5.10	-7.6264
PME Pro Medicus Ltd	3.49 1.88%	188.88	82.76	102.04	80.51	48.08	76.83	99.30
EIQ Echoiq Ltd	-0.025 1.55%	1.59	-	-	11740.24	61.80	11616.90	-8.2701
AYA ARTRYA Ltd	-0.07 1.33%	5.21	-	-	29733.68	9.65	9470.60	0.33
CGS Cogstate Ltd	-0.02 0.72%	2.76	30.89	25.32	8.42	6.33	5.47	17.04

Reports Covered

View All

Profile

Vitasora Health Limited researches, develops, and commercializes medical devices in Australia and the United States. It is also involved in the production of mobile health applications. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in Melbourne, Australia.

Vitasora Health Ltd

432 St Kilda Road, Melbourne, VIC, Australia, 3004

61 3 9653 9160
https://vitasorahealth.com.au

Key Executives

Name	Title	Year Born
Mr. Nicholas Smedley	Executive Chairman	NA
Mr. Marjan Mikel B.Sc., M.A.I.C.D.	CEO, MD & Executive Director	NA
Mr. Peter Hildebrandt	Chief Operations Officer	NA
Mr. George Vlachodimitropoulos	Chief Technology Officer	NA
Dr. Samaneh Sarraf Shirazi	Chief Research Officer	NA
Mr. Theo Antonopoulos	Chief Commercial Officer	NA
Mr. William Sigsbee	Head of US Operations & Chief Commercial Officer for the US market	NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA	Joint Company Secretary	NA
Ms. Nova Anne Taylor	Joint Company Secretary	NA
Prof. Noam Gavriely D.Sc., M.D.	Medical & Scientific Advisor	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.